General Statement of Disclosure:
OWNERSHIP/PARTNERSHIP/PRINCIPAL: Oxitope, Inc(SIGNIFICANT), Kleanthi Diagnostics(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Novartis Corporation(SIGNIFICANT) SALARY: Ionis Pharmaceuticals(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Patents via UCSD(MODEST)
